Articles Posted in Mass Torts

One piece of future litigation that is interesting is processed food childhood diabetes lawsuits. Our law firm is not currently handling lawsuits regarding childhood type 2 diabetes and non-alcoholic fatty liver disease linked to ultra-processed foods. But the prospect of future litigation is interesting and worth talking about.

Ulta-Processed Food Diabetes Lawsuit Updates

This litigation is moving forward quite quickly.  Here is the latest news and updates:

This page will look at Saxenda cancer and gastroparesis lawsuits. Saxenda is a weight loss drug that is similar to Ozempic. Several years ago, Saxenda was linked to an increased risk of pancreatic cancer. Now, new evidence has emerged that indicates that Saxenda might also cause a serious condition called gastroparesis (stomach paralysis).

Our firm is currently investigating Saxenda cases from anyone who used Saxenda for at least 6 months and was subsequently diagnosed with gastroparesis. Contact us at 800-553-8082 for a free consultation or get a free case evaluation online. Continue reading

On this page, our national mass tort lawyers will look at Call of Duty video game addiction lawsuits. We will look at the features of Call of Duty that are intended to make it highly addictive, the developer’s failure to warn about the addictive nature of the game and the harmful impacts of video game addiction. We will also look at the allegations and legal claims being made in video game addiction lawsuits across the country, and the potential settlement value of these cases.

• Video Game Addiction Lawsuits
• Roblox Addiction Lawsuits

Mounjaro is a diabetes drug manufactured by Eli Lilly. Recently, Mounjaro (and similar drugs like Ozempic and Wegovy) have become widely used for weight loss and weight management in obese patients. New evidence has emerged, however, showing that using higher doses of Mounjaro for weight loss can cause serious health problems involving the gallbladder and the gastrointestinal system. Mounjaro use has been linked to gallbladder disease, gallstones, gastroparesis (stomach paralysis), and other stomach conditions.

Eli Lilly apparently knew about these dangerous risks associated with Mounjaro but failed to warn doctors and patients about them. Individuals who used Mounjaro and suffered some of these injuries are now bringing Mounjaro product liability lawsuits. The national mass tort lawyers at Miller & Zois are investigating new Mounjaro injury cases. If you took Mounjaro for weight loss and suffered gastroparesis, contact us for a free case evaluation. Call us at 800-553-8082. Continue reading

Veozah (fezolinetant), a non-hormonal drug hailed as a breakthrough for managing menopausal hot flashes, was approved by the FDA in May 2023. Marketed as a safe alternative to hormone replacement therapies, Veozah quickly gained popularity among women seeking relief from debilitating vasomotor symptoms. However, the celebration was short-lived. Reports of severe liver injuries linked to the drug began to surface, prompting FDA interventions and spurring a wave of lawsuits.

Patients allege that Veozah’s manufacturer, Astellas Pharma, failed to adequately warn consumers and healthcare providers about the significant risks associated with its use. As the number of affected individuals grows, legal action is shedding light on the dangers of insufficient drug testing and corporate negligence.

Reverse Chronological Timeline of Key Events

In many ways, 2024 was an anti-climatic year in the world of mass torts. The 3M Earplugs settlement has been a disappointment for thousands of claimants. The rejection of J&J’s efforts to force the talc claims into bankruptcy has not prompted a major settlement and the hernia mesh claims continue to drag on. We did get a major global settlement in the AFFF litigation, but it only covered water contamination claims by local municipalities.

Let’s talk about what we can expect in 2025 in the mass tort class action lawsuits with the highest predicted settlement payouts.

Roundup

Our lawyers are handling Taxotere eye injury lawsuits throughout the United States for women with permanently watery eyes from docetaxel.

Taxotere (docetaxel) is a widely used breast cancer chemotherapy drug. New evidence has emerged showing that Taxotere may be causing some users to suffer permanent vision loss or damage.

This has led to a wave of product liability Taxotere lawsuits by women who claim that Taxotere damaged their eyesight. The manufacturer of Taxotere, Sanofi, allegedly knew about the risk of vision damage but chose not to warn doctors or patients about this risk.